1. Home
  2. TOVX vs NXRT Comparison

TOVX vs NXRT Comparison

Compare TOVX & NXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOVX
  • NXRT
  • Stock Information
  • Founded
  • TOVX 2001
  • NXRT 2014
  • Country
  • TOVX United States
  • NXRT United States
  • Employees
  • TOVX N/A
  • NXRT 2
  • Industry
  • TOVX Biotechnology: Pharmaceutical Preparations
  • NXRT Real Estate Investment Trusts
  • Sector
  • TOVX Health Care
  • NXRT Real Estate
  • Exchange
  • TOVX Nasdaq
  • NXRT Nasdaq
  • Market Cap
  • TOVX 3.8M
  • NXRT 859.4M
  • IPO Year
  • TOVX 2006
  • NXRT N/A
  • Fundamental
  • Price
  • TOVX $0.50
  • NXRT $34.14
  • Analyst Decision
  • TOVX Hold
  • NXRT Hold
  • Analyst Count
  • TOVX 1
  • NXRT 6
  • Target Price
  • TOVX N/A
  • NXRT $41.88
  • AVG Volume (30 Days)
  • TOVX 170.1K
  • NXRT 168.7K
  • Earning Date
  • TOVX 08-12-2025
  • NXRT 07-29-2025
  • Dividend Yield
  • TOVX N/A
  • NXRT 5.96%
  • EPS Growth
  • TOVX N/A
  • NXRT N/A
  • EPS
  • TOVX N/A
  • NXRT N/A
  • Revenue
  • TOVX N/A
  • NXRT $255,529,000.00
  • Revenue This Year
  • TOVX N/A
  • NXRT N/A
  • Revenue Next Year
  • TOVX N/A
  • NXRT $5.35
  • P/E Ratio
  • TOVX N/A
  • NXRT N/A
  • Revenue Growth
  • TOVX N/A
  • NXRT N/A
  • 52 Week Low
  • TOVX $0.40
  • NXRT $30.98
  • 52 Week High
  • TOVX $7.37
  • NXRT $48.37
  • Technical
  • Relative Strength Index (RSI)
  • TOVX 45.57
  • NXRT 51.80
  • Support Level
  • TOVX $0.42
  • NXRT $33.21
  • Resistance Level
  • TOVX $0.48
  • NXRT $34.58
  • Average True Range (ATR)
  • TOVX 0.03
  • NXRT 0.82
  • MACD
  • TOVX 0.02
  • NXRT 0.16
  • Stochastic Oscillator
  • TOVX 88.67
  • NXRT 79.29

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

About NXRT NexPoint Residential Trust Inc.

NexPoint Residential Trust Inc is a real estate investment trust company. Its objectives are to maximize the cash flow and value of properties owned, acquire properties with cash flow growth potential, provide quarterly cash distributions, and achieve long-term capital appreciation for stockholders. The company seeks to achieve these objectives through targeted management and a capex value-add program. It focuses on acquiring multifamily properties in markets with attractive job growth and household formation fundamentals predominantly in the Southeastern and Southwestern United States. The company generates revenue from the rental of multifamily properties.

Share on Social Networks: